{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:32:51Z","timestamp":1789813971505,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T00:00:00Z","timestamp":1416355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12026-014-8584-2","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T15:04:53Z","timestamp":1416582293000},"page":"117-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein\u2013Barr nuclear antigen-1, strongly cross-react with the peptide \u03b260-74Cit which bears the immunodominant epitope of citrullinated fibrin"],"prefix":"10.1007","volume":"61","author":[{"given":"M.","family":"Cornillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Verrouil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cantagrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Serre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,19]]},"reference":[{"key":"8584_CR1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semarthrit.2006.08.006","volume":"36","author":"Y Alamanos","year":"2006","unstructured":"Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006;36:182\u20138.","journal-title":"Semin Arthritis Rheum"},{"key":"8584_CR2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319.","journal-title":"N Engl J Med"},{"key":"8584_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.bor.0000160780.13012.be","volume":"17","author":"AH Helm-van Mil van der","year":"2005","unstructured":"van der Helm-van Mil AH, Wesoly JZ, Huizinga TW. Understanding the genetic contribution to rheumatoid arthritis. Curr Opin Rheumatol. 2005;17:299\u2013304.","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl","key":"8584_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2005.09.005","volume":"25","author":"RR Vries de","year":"2005","unstructured":"de Vries RR, Huizinga TW, Toes RE. Redefining the HLA and RA association: to be or not to be anti-CCP positive. J Autoimmun. 2005;25(Suppl):21\u20135.","journal-title":"J Autoimmun"},{"key":"8584_CR5","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar2421","volume":"10","author":"KH Costenbader","year":"2008","unstructured":"Costenbader KH, Chang SC, De Vivo I, Plenge R, Karlson EW. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res Ther. 2008;10:R52.","journal-title":"Arthritis Res Ther"},{"key":"8584_CR6","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/art.22597","volume":"56","author":"M Pedersen","year":"2007","unstructured":"Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, et al. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum. 2007;56:1446\u201353.","journal-title":"Arthritis Rheum"},{"key":"8584_CR7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0896-8411(89)90008-5","volume":"2","author":"HE Becker","year":"1989","unstructured":"Becker HE, Vierbuchen C, Federlin K. Influence of Epstein\u2013Barr virus infection on B lymphocyte responses in patients with rheumatoid arthritis. J Autoimmun. 1989;2:825\u201331.","journal-title":"J Autoimmun"},{"key":"8584_CR8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00271872","volume":"9","author":"M Lotz","year":"1989","unstructured":"Lotz M, Roudier J. Epstein\u2013Barr virus and rheumatoid arthritis: cellular and molecular aspects. Rheumatol Int. 1989;9:147\u201352.","journal-title":"Rheumatol Int"},{"key":"8584_CR9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jbspin.2007.05.001","volume":"74","author":"E Toussirot","year":"2007","unstructured":"Toussirot E, Roudier J. Pathophysiological links between rheumatoid arthritis and the Epstein\u2013Barr virus: an update. Joint Bone Spine. 2007;74:418\u201326.","journal-title":"Joint Bone Spine"},{"key":"8584_CR10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.virusres.2006.01.002","volume":"117","author":"DJ McGeoch","year":"2006","unstructured":"McGeoch DJ, Rixon FJ, Davison AJ. Topics in herpesvirus genomics and evolution. Virus Res. 2006;117:90\u2013104.","journal-title":"Virus Res"},{"key":"8584_CR11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","volume":"1","author":"JL Kutok","year":"2006","unstructured":"Kutok JL, Wang F. Spectrum of Epstein\u2013Barr virus-associated diseases. Annu Rev Pathol. 2006;1:375\u2013404.","journal-title":"Annu Rev Pathol"},{"key":"8584_CR12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","volume":"9","author":"GJ Babcock","year":"1998","unstructured":"Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity. 1998;9:395\u2013404.","journal-title":"Immunity"},{"key":"8584_CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson DA. Epstein\u2013Barr virus: exploiting the immune system. Nat Rev Immunol. 2001;1:75\u201382.","journal-title":"Nat Rev Immunol"},{"key":"8584_CR14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbrc.2010.02.146","volume":"396","author":"G Klein","year":"2010","unstructured":"Klein G, Klein E, Kashuba E. Interaction of Epstein\u2013Barr virus (EBV) with human B-lymphocytes. Biochem Biophys Res Commun. 2010;396:67\u201373.","journal-title":"Biochem Biophys Res Commun"},{"key":"8584_CR15","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1084\/jem.147.4.1018","volume":"147","author":"MA Alspaugh","year":"1978","unstructured":"Alspaugh MA, Jensen FC, Rabin H, Tan EM. Lymphocytes transformed by Epstein\u2013Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med. 1978;147:1018\u201327.","journal-title":"J Exp Med"},{"key":"8584_CR16","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1073\/pnas.80.23.7104","volume":"80","author":"PB Billings","year":"1983","unstructured":"Billings PB, Hoch SO, White PJ, Carson DA, Vaughan JH. Antibodies to the Epstein\u2013Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc Natl Acad Sci USA. 1983;80:7104\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8584_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00271874","volume":"9","author":"C Baboonian","year":"1989","unstructured":"Baboonian C, Halliday D, Venables PJ, Pawlowski T, Millman G, Maini RN. Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein\u2013Barr nuclear antigen-1. Rheumatol Int. 1989;9:161\u20136.","journal-title":"Rheumatol Int"},{"key":"8584_CR18","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1073\/pnas.76.11.5825","volume":"76","author":"MA Catalano","year":"1979","unstructured":"Catalano MA, Carson DA, Slovin SF, Richman DD, Vaughan JH. Antibodies to Epstein\u2013Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci USA. 1979;76:5825\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8584_CR19","first-page":"1029","volume":"16","author":"T Yokochi","year":"1989","unstructured":"Yokochi T, Yanagawa A, Kimura Y, Mizushima Y. High titer of antibody to the Epstein\u2013Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol. 1989;16:1029\u201332.","journal-title":"J Rheumatol"},{"key":"8584_CR20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/art.10933","volume":"48","author":"N Balandraud","year":"2003","unstructured":"Balandraud N, Meynard JB, Auger I, Sovran H, Mugnier B, Reviron D, et al. Epstein\u2013Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum. 2003;48:1223\u20138.","journal-title":"Arthritis Rheum"},{"key":"8584_CR21","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM198111193052102","volume":"305","author":"G Tosato","year":"1981","unstructured":"Tosato G, Steinberg AD, Blaese RM. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med. 1981;305:1238\u201343.","journal-title":"N Engl J Med"},{"key":"8584_CR22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4049\/jimmunol.181.2.991","volume":"181","author":"JD Lunemann","year":"2008","unstructured":"Lunemann JD, Frey O, Eidner T, Baier M, Roberts S, Sashihara J, et al. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol. 2008;181:991\u20131000.","journal-title":"J Immunol"},{"key":"8584_CR23","first-page":"239","volume":"32","author":"T Klatt","year":"2005","unstructured":"Klatt T, Ouyang Q, Flad T, Koetter I, Buhring HJ, Kalbacher H, et al. Expansion of peripheral CD8+ CD28\u2212 T cells in response to Epstein\u2013Barr virus in patients with rheumatoid arthritis. J Rheumatol. 2005;32:239\u201351.","journal-title":"J Rheumatol"},{"key":"8584_CR24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar1893","volume":"8","author":"KH Costenbader","year":"2006","unstructured":"Costenbader KH, Karlson EW. Epstein\u2013Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther. 2006;8:204.","journal-title":"Arthritis Res Ther"},{"key":"8584_CR25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.21629","volume":"54","author":"F Pratesi","year":"2006","unstructured":"Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P. Deiminated Epstein\u2013Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2006;54:733\u201341.","journal-title":"Arthritis Rheum"},{"key":"8584_CR26","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2012-202352","volume":"72","author":"C Croia","year":"2012","unstructured":"Croia C, Serafini B, Bombardieri M, Kelly S, Humby F, Severa M, et al. Epstein\u2013Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis. 2012;72:1559\u201368.","journal-title":"Ann Rheum Dis"},{"key":"8584_CR27","doi-asserted-by":"crossref","unstructured":"Sebbag M, Clavel C, Nogueira L, Arnaud J, Serre G. Autoimmune response to posttranslationally modified (citrullinated) proteins: prime suspect in the pathophysiology of rheumatoid arthritis. In: Zouali M, editor. The epigenetics of autoimmune diseases. Chichester:Wiley; 2009. p. 279\u2013308. doi: 10.1002\/9780470743553 .","DOI":"10.1002\/9780470743553"},{"key":"8584_CR28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380\u20136.","journal-title":"Arthritis Rheum"},{"key":"8584_CR29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.23.4.302","volume":"23","author":"RL Nienhuis","year":"1964","unstructured":"Nienhuis RL, Mandema E. A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor. Ann Rheum Dis. 1964;23:302\u20135.","journal-title":"Ann Rheum Dis"},{"key":"8584_CR30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","volume":"162","author":"E Girbal-Neuhauser","year":"1999","unstructured":"Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol. 1999;162:585\u201394.","journal-title":"J Immunol."},{"key":"8584_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998;101:273\u201381.","journal-title":"J Clin Invest"},{"key":"8584_CR32","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","volume":"166","author":"C Masson-Bessi\u00e8re","year":"2001","unstructured":"Masson-Bessi\u00e8re C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001;166:4177\u201384.","journal-title":"J Immunol"},{"key":"8584_CR33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/rheumatology\/ken077","volume":"47","author":"K Tilleman","year":"2008","unstructured":"Tilleman K, Van Steendam K, Cantaert T, De Keyser F, Elewaut D, Deforce D. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology (Oxford). 2008;47:597\u2013604.","journal-title":"Rheumatology (Oxford)"},{"key":"8584_CR34","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","volume":"7","author":"A Kinloch","year":"2005","unstructured":"Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther. 2005;7:R1421\u20139.","journal-title":"Arthritis Res Ther"},{"key":"8584_CR35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2249.2004.02708.x","volume":"139","author":"S Chapuy-Regaud","year":"2005","unstructured":"Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol. 2005;139:542\u201350.","journal-title":"Clin Exp Immunol"},{"key":"8584_CR36","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ard.2004.029389","volume":"64","author":"MM Nielen","year":"2005","unstructured":"Nielen MM, van der Horst AR, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, Aarden L, et al. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis. 2005;64:1199\u2013204.","journal-title":"Ann Rheum Dis"},{"key":"8584_CR37","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar2011","volume":"8","author":"B Cruyssen Vander","year":"2006","unstructured":"Vander Cruyssen B, Cantaert T, Nogueira L, Clavel C, De Rycke L, Dendoven A, et al. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther. 2006;8:R122.","journal-title":"Arthritis Res Ther"},{"key":"8584_CR38","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200535790","volume":"36","author":"M Sebbag","year":"2006","unstructured":"Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol. 2006;36:2250\u201363.","journal-title":"Eur J Immunol"},{"key":"8584_CR39","author":"M Cornillet","year":"2014","unstructured":"Cornillet M, Sebbag M, Verrouil E, Magyar A, Babos F, Ruyssen-Witrand A, et al. The fibrin-derived citrullinated peptide beta60-74Cit60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies. Ann Rheum Dis. 2014. doi: 10.1136\/annrheumdis-2012-202868 .","journal-title":"Ann Rheum Dis"},{"key":"8584_CR40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/jaut.1994.1014","volume":"7","author":"B Marchini","year":"1994","unstructured":"Marchini B, Dolcher MP, Sabbatini A, Klein G, Migliorini P. Immune response to different sequences of the EBNA I molecule in Epstein\u2013Barr virus-related disorders and in autoimmune diseases. J Autoimmun. 1994;7:179\u201391.","journal-title":"J Autoimmun"},{"key":"8584_CR41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1196\/annals.1313.025","volume":"1050","author":"G Merlini","year":"2005","unstructured":"Merlini G, Anzilotti C, Chimenti D, Tommasi C, Bombardieri S, Migliorini P. A deiminated viral peptide to detect antibodies in rheumatoid arthritis. Ann N Y Acad Sci. 2005;1050:243\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"8584_CR42","first-page":"647","volume":"33","author":"C Anzilotti","year":"2006","unstructured":"Anzilotti C, Merlini G, Pratesi F, Tommasi C, Chimenti D, Migliorini P. Antibodies to viral citrullinated peptide in rheumatoid arthritis. J Rheumatol. 2006;33:647\u201351.","journal-title":"J Rheumatol"},{"key":"8584_CR43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"key":"8584_CR44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jaut.2011.07.003","volume":"37","author":"C Iobagiu","year":"2011","unstructured":"Iobagiu C, Magyar A, Nogueira L, Cornillet M, Sebbag M, Arnaud J, et al. The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted. J Autoimmun. 2011;37:263\u201372.","journal-title":"J Autoimmun"},{"key":"8584_CR45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-1781(96)02952-6","volume":"69","author":"DP McKenzie","year":"1997","unstructured":"McKenzie DP, Vida S, Mackinnon AJ, Onghena P, Clarke DM. Accurate confidence intervals for measures of test performance. Psychiatry Res. 1997;69:207\u20139.","journal-title":"Psychiatry Res"},{"key":"8584_CR46","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0197-2456(96)00129-8","volume":"18","author":"J Zhang","year":"1997","unstructured":"Zhang J, Quan H, Ng J, Stepanavage ME. Some statistical methods for multiple endpoints in clinical trials. Control Clin Trials. 1997;18:204\u201321.","journal-title":"Control Clin Trials"},{"key":"8584_CR47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2249.2011.04378.x","volume":"164","author":"F Pratesi","year":"2011","unstructured":"Pratesi F, Tommasi C, Anzilotti C, Puxeddu I, Sardano E, Di Colo G, et al. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies. Clin Exp Immunol. 2011;164:337\u201345.","journal-title":"Clin Exp Immunol"},{"key":"8584_CR48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.2010.131102","volume":"70","author":"A Ioan-Facsinay","year":"2011","unstructured":"Ioan-Facsinay A, el-Bannoudi H, Scherer HU, van der Woude D, Menard HA, Lora M, et al. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis. 2011;70:188\u201393.","journal-title":"Ann Rheum Dis"},{"key":"8584_CR49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20121486","volume":"210","author":"K Amara","year":"2013","unstructured":"Amara K, Steen J, Murray F, Morbach H, Fernandez-Rodriguez BM, Joshua V, et al. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med. 2013;210:445\u201355.","journal-title":"J Exp Med"},{"key":"8584_CR50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.2010.132662","volume":"70","author":"LA Stadt van de","year":"2011","unstructured":"van de Stadt LA, van der Horst AR, de Koning MH, Bos WH, Wolbink GJ, van de Stadt RJ, et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis. 2011;70:128\u201333.","journal-title":"Ann Rheum Dis"},{"key":"8584_CR51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/annrheumdis-2011-200421","volume":"71","author":"A Willemze","year":"2012","unstructured":"Willemze A, Bohringer S, Knevel R, Levarht EW, Stoeken-Rijsbergen G, Houwing-Duistermaat JJ, et al. The ACPA recognition profile and subgrouping of ACPA-positive RA patients. Ann Rheum Dis. 2012;71:268\u201374.","journal-title":"Ann Rheum Dis"},{"key":"8584_CR52","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/1385272033486161","volume":"7","author":"XM Cai","year":"2003","unstructured":"Cai XM, Dass C. Conformational analysis of proteins and peptides. Curr Org Chem. 2003;7:1841\u201354.","journal-title":"Curr Org Chem"},{"key":"8584_CR53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/prca.200900088","volume":"4","author":"M Hermansson","year":"2010","unstructured":"Hermansson M, Artemenko K, Ossipova E, Eriksson H, Lengqvist J, Makrygiannakis D, et al. MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen. Proteomics Clin Appl. 2010;4:511\u20138.","journal-title":"Proteomics Clin Appl"},{"key":"8584_CR54","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/pr500030x","volume":"13","author":"AE Tutturen","year":"2014","unstructured":"Tutturen AE, Fleckenstein B, de Souza GA. Assessing the citrullinome in rheumatoid arthritis synovial fluid with and without enrichment of citrullinated peptides. J Proteome Res. 2014;13:2867\u201373.","journal-title":"J Proteome Res"},{"key":"8584_CR55","author":"F Humby","year":"2009","unstructured":"Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009;. doi: 10.1371\/journal.pmed.0060001 .","journal-title":"PLoS Med"},{"key":"8584_CR56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","volume":"9","author":"RG Caldwell","year":"1998","unstructured":"Caldwell RG, Wilson JB, Anderson SJ, Longnecker R. Epstein\u2013Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity. 1998;9:405\u201311.","journal-title":"Immunity"},{"key":"8584_CR57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","volume":"286","author":"J Uchida","year":"1999","unstructured":"Uchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwichit W, Raab-Traub N, et al. Mimicry of CD40 signals by Epstein\u2013Barr virus LMP1 in B lymphocyte responses. Science. 1999;286:300\u20133.","journal-title":"Science"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8584-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-014-8584-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8584-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T11:45:49Z","timestamp":1689680749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-014-8584-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,19]]},"references-count":57,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["8584"],"URL":"https:\/\/doi.org\/10.1007\/s12026-014-8584-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,19]]}}}